A need for bedside surrogates of ventriculoarterial coupling in critical care – can MAPSE be of help? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring the Role of MAPSE as a Bedside Indicator for Ventriculoarterial Coupling in Critical Care Settings

  • By

  • Jinyang Yu

  • October 5, 2026

Share

Clinical Scorecard: Exploring the Role of MAPSE as a Bedside Indicator for Ventriculoarterial Coupling in Critical Care Settings

At a Glance

CategoryDetail
ConditionVentriculoarterial Coupling
Key MechanismsMechanical energy efficiency of the left ventricle
Target PopulationCritically ill patients
Care SettingCritical care settings

Key Highlights

  • VA coupling responses are unpredictable and correlate weakly with cardiac output changes.
  • MAPSE may serve as a bedside surrogate for VA coupling.
  • MAPSE has strong prognostic value among critically ill patients.
  • Current monitoring strategies for VA coupling are time-consuming and complex.
  • Correlation between MAPSE and non-invasive VA coupling estimates requires further validation.

Guideline-Based Recommendations

Diagnosis

  • MAPSE is acknowledged in several critical care guidelines.

Management

  • Monitoring and optimizing VA coupling is important for hemodynamic optimization.

Monitoring & Follow-up

  • Effective monitoring strategies for VA coupling are currently lacking.

Risks

  • Poor VA coupling may increase the risk of cardiac decompensation.

Patient & Prescribing Data

Critically ill patients requiring hemodynamic monitoring.

MAPSE may provide insights into therapeutic effects and VA coupling optimization.

Clinical Best Practices

  • Utilize MAPSE as a potential bedside surrogate for VA coupling.
  • Consider serial monitoring of VA coupling for hemodynamic optimization.

Related Resources & Content

Original Source(s)

Related Content